http://www.zibb.com/healthcare/theme/cq/ACADIA+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 24 Nov 2009 18:58:27 GMTTue, 24 Nov 2009 18:58:27 GMT608831http://www.zibb.com/healthcare/theme/cq/ACADIA+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.pharmacychoice.com/News/article.cfm?Article_ID=45105A live webcast of ACADIA's presentation will be accessible on the company's website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through January 25, 2007. About ACADIA Pharmaceuticalshttp://www.pharmacychoice.com/News/article.cfm?Article_ID=45105ACADIA Pharmaceuticals Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=107500&category=1Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=107500&category=1ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=16563ACP-104 is currently being evaluated in three clinical trials, all of which are being conducted in patients with schizophrenia and in collaboration with Professor Carol Tamminga, M.D.http://www.pharmacychoice.com/News/article.cfm?Article_ID=16563ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=10318and 617-801-6888 for international callers (reference passcode 28397094). The conference call also will be webcast live on ACADIA's website, www.acadia-pharm.http://www.pharmacychoice.com/News/article.cfm?Article_ID=10318ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=14056Under a collaboration between ACADIA and Allergan, the companies have discovered and are developing a new class of small molecule drug candidates that may be effective in treating a range of neuropathic pain conditions.http://www.pharmacychoice.com/News/article.cfm?Article_ID=14056ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=31333The results of these studies demonstrated that ACP-104 is safe and well tolerated after repeated dosing of up to 600 mg per day, and that initial signals of antipsychotic effects were observed within the tolerated dose range of ACP-104.http://www.pharmacychoice.com/News/article.cfm?Article_ID=31333ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=32825-- The Bank of America 2006 Specialty Pharmaceuticals Conference on Friday, August 11, 2006, at 9:45 a.m. Eastern Time at the Southampton Inn in Southampton, New York. Live webcasts of these presentations will be accessible on the company's website, www.acadia-pharm.http://www.pharmacychoice.com/News/article.cfm?Article_ID=32825ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=327358/2/06 - ACADIA Pharmaceuticals to Announce Second Quarter 2006 Financial Results on August 8, 2006; ACADIA to Host Conference Call and Webcast on Tuesday, August 8, 2006, at 5:00 p.m.http://www.pharmacychoice.com/News/article.cfm?Article_ID=32735ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=37022ACADIA reported that enrollment in the clinical trial is significantly ahead of schedule, which should enable the company to report top-line results for the complete 400-patient clinical trial during the first quarter of 2007, ahead of earlier expectations.http://www.pharmacychoice.com/News/article.cfm?Article_ID=37022ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=36021-- The 2006 UBS Global Life Sciences Conference on Tuesday, September 26, 2006, at 12:30 p.m. Eastern Time at the Grand Hyatt New York Hotel in New York City. Live webcasts of these presentations will be accessible on the company's website, www.acadia-pharm.http://www.pharmacychoice.com/News/article.cfm?Article_ID=36021ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=7437The ongoing double-blind, placebo-controlled, dose-escalation Phase II clinical trial is designed to evaluate the efficacy and tolerability of ACP-103 in 60 Parkinson's disease patients who suffer from treatment-induced psychosis.http://www.pharmacychoice.com/News/article.cfm?Article_ID=7437ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=2963and 617-801-6888 for international callers (reference passcode 89884568). The conference call also will be webcast live on ACADIA's website, www.acadia-pharm.http://www.pharmacychoice.com/News/article.cfm?Article_ID=2963ACADIA Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=50675S. financial markets close. ACADIA's management will host a conference call and webcast on Tuesday, March 6, 2007 at 5:00 p.m. Eastern Time to discuss ACADIA's financial results and development programs.http://www.pharmacychoice.com/News/article.cfm?Article_ID=50675ACADIA Pharmaceuticals Incorporated